Pharmaceutical Executive-08-01-2019

Pharmaceutical Executive

A Look Back & Forward on Innovation

August 20, 2019

From the Editor

39

8

In a sit-down with editors from our group publications, former FDA Commissioner Scott Gottlieb chatted with Pharm Exec on several topics, including the evolution of pricing and reimbursement for novel therapies-and the access fixes needed for future.

The Call to Cure: Geoff MacKay, AVROBIO

August 12, 2019

Features

39

8

Pharm Exec speaks with Geoff MacKay, co-founder and CEO of AVROBIO, about the company’s mission to advance potentially curative lentiviral-based gene therapies, his career building businesses and innovation in regenerative medicine, and his most important quest to date-moving gene therapy into the mainstream.

Mapping Out the Future of Cell and Gene Therapy

August 08, 2019

Features

39

8

The cell and gene therapy space remains fertile territory for growth, exploration, and discovery. How applying a data-driven model may be the best way to approach this complex ecosystem and assess the innovations of tomorrow.

Gene Therapy: How ‘Advanced’ is Europe?

August 08, 2019

Features

39

8

Exploring the EU’s struggles and new efforts in promoting cell and gene drugs.

Using FDA’s ‘PIE’ Recipe to Enhance Patient Access

August 01, 2019

Columns

39

8

How R&D organizations can leverage FDA’s final guidance on pre-approval information exchange (PIE) to engage with payers prior to approval and launch.

Pharmaceutical Executive, August 2019 Issue (PDF)

August 01, 2019

Issue PDF

39

8

Click the title above to open the Pharmaceutical Executive August 2019 issue in an interactive PDF format.

Country Report: Spain

August 01, 2019

Special Sponsored Section

39

8

With Spain enjoying an economic rebound, pharma and medtech multinationals are seeing the country as a top-tier investment destination once more-thanks to improved market access, quality but affordable manufacturing capabilities, and an enviable clinical research base.